Adage Capital Partners’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-400,000
| Closed | -$10.8M | – | 1055 |
|
|
2022
Q2 | $10.8M | Sell |
400,000
-400,000
| -50% | -$10.8M | 0.02% | 654 |
|
|
2022
Q1 | $27.2M | Buy |
800,000
+150,000
| +23% | +$5.11M | 0.05% | 367 |
|
|
2021
Q4 | $25.1M | Sell |
650,000
-300,000
| -32% | -$11.6M | 0.05% | 396 |
|
|
2021
Q3 | $51.3M | Sell |
950,000
-868,478
| -48% | -$46.9M | 0.1% | 209 |
|
|
2021
Q2 | $60.8M | Sell |
1,818,478
-81,522
| -4% | -$2.73M | 0.12% | 180 |
|
|
2021
Q1 | $39.1M | Sell |
1,900,000
-600,000
| -24% | -$12.4M | 0.08% | 263 |
|
|
2020
Q4 | $43.8M | Buy |
2,500,000
+450,000
| +22% | +$7.88M | 0.1% | 225 |
|
|
2020
Q3 | $30.4M | Buy |
2,050,000
+300,000
| +17% | +$4.45M | 0.08% | 274 |
|
|
2020
Q2 | $22.8M | Buy |
+1,750,000
| New | +$22.8M | 0.06% | 358 |
|